Women’s Health Research at Yale is dedicated to ensuring that our community’s health needs are represented in the national conversation on health research and policy. Led by Director Carolyn M. Mazure, Ph.D., WHRY provides outreach on women’s health research to local, regional, national, and global communities and policymakers.
For example, Dr. Mazure was invited to speak at the United Nations for the Annual Ideagen Empowering Women & Girls 2030 Summit in September. Addressing industry leaders across sectors gathered to discuss solutions to meet the UN’s sustainable development goals, Dr. Mazure underscored the importance of ensuring that plans for improving the health of women are tied to economic security and advancement.
Dr. Mazure also spoke at an invitation-only meeting in October at the United Hospital Fund in New York, founded in 1879. This nonprofit organization forges private-government partnerships to improve community health. The meeting focused on helping state and city policymakers understand how the opioid crisis is affecting women and families.
Later that month, Dr. Mazure spoke at The Leaders in Women's Health Summit at The Laura W. Bush Institute for Women's Health in Dallas, Texas. Dr. Mazure was one of the first to join this group, which brings together leaders in women’s health from across the country to set collaborative goals addressing women’s health research and faculty careers for women.
Another prominent way in which WHRY leads national efforts in women’s health is through Dr. Mazure’s elected membership on the National Institutes of Health Office for Research on Women’s Health (ORWH) Advisory Committee. In this role, Dr. Mazure has a direct line into the national discourse on the status of contemporary research in this field and into the data stream on women’s health provided to communities across the nation.
This winter, Dr. Mazure will serve as a subject matter expert at the invitation of ORWH Director Janine Austin Clayton, M.D., to develop a new online training course for researchers and clinicians on consideration of sex as a biological variable. Dr. Mazure’s guidance will make sure that the course represents a comprehensive and useful resource for training future caregivers and investigators as they treat patients, design their studies, and prepare NIH grant applications with an eye toward fully analyzing their data to account for the possible influence of sex and gender.
And next year, Dr. Mazure will speak on the state of women’s health research before influential audiences at The University of Bordeaux and Sorbonne University in France, where two of her mentees, Drs. Mathilde Husky and Joel Swendsen, respectively, now work as full professors.